SCHEMBL5354776

SCHEMBL5354776

Cc1ccc(N(c2ccccc2)c2ccc(C=O)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.61
ALDH1A1 P00352 6/20 0.52
ALDH3A1 P30838 1/20 0.52
ALDH1A3 P47895 1/20 0.52
CYP2A13 Q16696 1/20 0.50
TRPM8 Q7Z2W7 2/20 0.47
MAPT P10636 3/20 0.42
CYP2C19 P33261 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CYP3A4 P08684 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
APP P05067 2/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14047565 1.00 CYP2A6 (0.61) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL18892841 1.00 CYP2A6 (0.61) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL11230768 1.00 CYP2A6 (0.61) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL19222015 1.00 CYP2A6 (0.61) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL7750929 0.95 CYP2A6 (0.55) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL17755573 0.95 CYP2A6 (0.55) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL18892895 0.95 CYP2A6 (0.55) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL3340810 0.92 CYP2A6 (0.73) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL13158697 0.92 CYP2A6 (0.73) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13
SCHEMBL339173 0.92 CYP2A6 (0.73) CYP2A6ALDH1A1ALDH3A1ALDH1A3CYP2A13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196225-B2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2007-03-27 US disclosed
US-7196225-B2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2007-03-27 US disclosed
US-7196225-B2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2007-03-27 US disclosed
EP-1090911-B1 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORP (JP) 2006-08-30 EP disclosed
US-20060178522-A1 BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF JOLED INC. (JP) 2006-08-10 US disclosed
US-7049470-B1 Bis (aminostyryl) anthracene compound, synthesis is intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2006-05-23 US disclosed
US-6979746-B2 (1,4-phenylene)bis(methylene) phosphonic acid esters and (1,4-phenylene)bis(methylene) triphenyl phosphonium salt compounds SONY CORPORATION (JP) 2005-12-27 US disclosed
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-04-17 US disclosed
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates JOLED INC. (JP) 2003-04-10 US disclosed
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates ICHIMURA MARI (JP) 2003-03-27 US disclosed
US-6525212-B1 Reacting 4-(N,N-diaryl)aminobenzaldehyde and diphosphonic acid ester or diphosphonium salt SONY CORPORATION (JP) 2003-02-25 US disclosed
US-6337167-B1 FOR USE AS AN ORGANIC LUMINESCENT MATERIAL CAPABLE OF DEVELOPING A DESIRED LUMINESCENT COLOR SONY CORPORATION (JP) 2002-01-08 US disclosed
EP-1090911-A2 Bis(aminostyryl) anthracene compound, synthesis intermediate thereof, and process for production thereof SONY CORPORATION (JP) 2001-04-11 EP disclosed
EP-0812820-B1 TRIPHENYLAMINE DERIVATIVES, AND CHARGE TRANSPORT MATERIAL AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM TAKASAGO PERFUMERY CO LTD (JP) 2001-01-17 EP disclosed
US-6090514-A ELECTROPHOTOSENSITIVE MATERIAL COMPRISING CONDUCTIVE SUBSTRATE AND SINGLE PHOTOSENSITIVE LAYER CONTAINING STILBENE DERIVATIVE AS HOLE TRANSFERRING MATERIAL MITA INDUSTRIAL CO., LTD. (JP) 2000-07-18 US disclosed
WO-1998021521-A9 TWO-PHOTON OR HIGHER-ORDER ABSORBING OPTICAL MATERIALS AND METHODS OF USE CALIFORNIA INST OF TECHN (US) 2000-03-02 WO disclosed
EP-0812820-A1 TRIPHENYLAMINE DERIVATIVES, AND CHARGE TRANSPORT MATERIAL AND ELECTROPHOTOGRAPHIC PHOTORECEPTOR PREPARED THEREFROM Takasago International Corporation (JP) 1997-12-17 EP disclosed
EP-0144791-A2 Photoreceptor KONICA CORPORATION (JP) 1985-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030060652-A1 Bis (aminostyryl) benzene compounds and synthetic intemediates thereof, and process for preparing the compounds and intermediates INTS6, IDH3B, IDH3A CYP2A6 1094/4885ALDH1A1 531/4885ALDH3A1 463/4885
US-20030073863-A1 Bis (aminostyryl) benzene compounds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, CCNB1, AASDHPPT CYP2A6 693/4885ALDH1A1 1346/4885ALDH3A1 842/4885
US-20030069437-A1 Bis (aminostyryl) benzene compunds and synthetic intermediates thereof, and process for preparing the compounds and intermediates DDC, AASDHPPT, DHPS CYP2A6 475/4885ALDH1A1 1431/4885ALDH3A1 1094/4885
US-20060178522-A1 BIS(AMINOSTYRYL) ANTHRACENE COMPOUND, SYNTHESIS INTERMEDIATE THEREOF, AND PROCESS FOR PRODUCTION THEREOF AASDHPPT, DDC, AADAT CYP2A6 384/4885ALDH1A1 782/4885ALDH3A1 584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.